Concepedia

Merav Yogev‐Falach

MY

Statistics

Publications

8

Citations

513

H-Index

8

Active since

2002

Affiliations

Technion – Israel Institute of Technology(Current)

Hebrew University of Jerusalem

Lev Hasharon Hospital

Merav Yogev‐Falach is an author at Technion – Israel Institute of Technology specializing in neuroscience, molecular neuroscience, and pharmacology.

Publications per year

2002–2009

8

Publications

8

The importance of propargylamine moiety in the anti‐ Parkinson drug rasagiline and its derivatives for MAPK‐ dependent amyloid precursor protein processing

Merav Yogev‐Falach, Tamar Amit, Orit Bar‐Am et al. · The FASEB Journal · 2003 · 117 citations

, , +12

Regulation of protein kinase C by the anti‐Parkinson drug, MAO‐B inhibitor, rasagiline and its derivatives, <i>in vivo</i>

Orit Bar‐Am, Merav Yogev‐Falach, Tamar Amit et al. · Journal of Neurochemistry · 2004 · 108 citations

, , +17

The involvement of mitogen‐activated protein (MAP) kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline

Merav Yogev‐Falach, Tamar Amit, Orit Bar‐Am et al. · The FASEB Journal · 2002 · 104 citations

, , +17

A multifunctional, neuroprotective drug, ladostigil (TV3326), regulates holo‐APP translation and processing

Merav Yogev‐Falach, Orit Bar‐Am, Tamar Amit et al. · The FASEB Journal · 2006 · 86 citations

, , +17

Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis

Hagit Grimberg, Galit Levin, Anat Shirvan et al. · APOPTOSIS · 2009 · 46 citations

, , +14

1–5 of 8